Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures.

نویسندگان

  • Daniel H Wolf
  • Theodore D Satterthwaite
  • Jacob J Kantrowitz
  • Natalie Katchmar
  • Lillie Vandekar
  • Mark A Elliott
  • Kosha Ruparel
چکیده

Motivational deficits play a central role in disability caused by schizophrenia and constitute a major unmet therapeutic need. Negative symptoms have previously been linked to hypofunction in ventral striatum (VS), a core component of brain motivation circuitry. However, it remains unclear to what extent this relationship holds for specific negative symptoms such as amotivation, and this question has not been addressed with integrated behavioral, clinical, and imaging measures. Here, 41 individuals with schizophrenia and 37 controls performed a brief, computerized progressive ratio task (PRT) that quantifies effort exerted in pursuit of monetary reward. Clinical amotivation was assessed using the recently validated Clinical Assessment Interview for Negative Symptoms (CAINS). VS function was probed during functional magnetic resonance imaging using a monetary guessing paradigm. We found that individuals with schizophrenia had diminished motivation as measured by the PRT, which significantly and selectively related to clinical amotivation as measured by the CAINS. Critically, lower PRT motivation in schizophrenia was also dimensionally related to VS hypofunction. Our results demonstrate robust dimensional associations between behavioral amotivation, clinical amotivation, and VS hypofunction in schizophrenia. Integrating behavioral measures such as the PRT will facilitate translational efforts to identify biomarkers of amotivation and to assess response to novel therapeutic interventions.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Abbreviated quality of life scales for schizophrenia: comparison and utility of two brief community functioning measures.

BACKGROUND The Heinrichs-Carpenter Quality of Life Scale (QLS) is the most extensively used real-world community functioning scale in schizophrenia research. However, the extensive time required to administer it and the inclusion of items that overlap conceptually with negative symptoms limit its use across studies. The present study examined the validity and utility of two abbreviated QLS meas...

متن کامل

Altered cingulo-striatal function underlies reward drive deficits in schizophrenia.

Amotivation in schizophrenia is assumed to involve dysfunctional dopaminergic signaling of reward prediction or anticipation. It is unclear, however, whether the translation of neural representation of reward value to behavioral drive is affected in schizophrenia. In order to examine how abnormal neural processing of response valuation and initiation affects incentive motivation in schizophreni...

متن کامل

اثربخشی درمان گروهی ترمیم شناختی در بیماران مبتلا به اسکیزوفرنیا با سیر طولی

Objectives: The present research investigates the efficacy of Group Cognitive-Remediation Therapy (GCRT) in decreasing clinical symptoms and enhancing cognitive performance among patients with schizophrenia. Method: Forty subjects were randomly selected from inpatients with at Razi Psychiatry Schizophrenia Hospital, and were assigned to one experimental and one control group, each one comprisin...

متن کامل

Baseline social amotivation predicts 1-year functioning in UHR subjects: A validation and prospective investigation.

Social amotivation and diminished expression have been reported to underlie negative symptomatology in schizophrenia. In the current study we sought to establish and validate these negative symptom domains in a large cohort of schizophrenia subjects (n=887) and individuals who are deemed to be Ultra-High Risk (UHR) for psychosis. Confirmatory factor analysis conducted on PANSS item domains demo...

متن کامل

Survey of the effect of memantine on negative sign in patients with schizophrenia and schizoaffective disorders

Aim: The aim of this study is to evaluate the effect of memantine on negative symptoms in patients with schizophrenia and schizoaffective. Methods: This is a double- blind randomized clinical trial. 58 patients participated in the study, 29 patients were randomly assigned to the memantine group and 29 patients to the placebo group. For assessing negative signs, and we used scale for the assess...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Schizophrenia bulletin

دوره 40 6  شماره 

صفحات  -

تاریخ انتشار 2014